M&A Deal Summary

Edwards Acquires Valtech Cardio

On November 28, 2016, Edwards acquired medical products company Valtech Cardio from HeartWare International for 340M USD

Acquisition Highlights
  • This is Edwards’ 8th transaction in the Medical Products sector.
  • This is Edwards’ 2nd largest (disclosed) transaction.
  • This is Edwards’ 1st transaction in Israel.

M&A Deal Summary
Date 2016-11-28
Target Valtech Cardio
Sector Medical Products
Buyer(s) Edwards
Sellers(s) HeartWare International
Deal Type Divestiture
Deal Value 340M USD

Target

Valtech Cardio

Yehuda, Israel
Valtech Cardio Ltd. is specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR).

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Edwards

Irvine, California, United States
Category Company
Founded 1958
Sector Medical Products
Employees19,800
Revenue 6.0B USD (2023)
DESCRIPTION
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.

Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.

DEAL STATS #
Overall 11 of 15
Sector (Medical Products) 8 of 12
Type (Divestiture) 5 of 5
Country (Israel) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 2 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-26 CardiAQ Valve Technologies

Irvine, California, United States

CardiAQ Valve Technologies, Inc. is a developer of a transcatheter mitral valve replacement system.

Buy $400M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-06 Harpoon Medical

Baltimore, Maryland, United States

Harpoon Medical, Inc. is a medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR). Harpoon Medical is based in Baltimore, Maryland.

Buy $100M

Seller(S) 1

SELLER

HeartWare International

Framingham, Massachusetts, United States
Category Company
Sector Medical Products
Employees625
Revenue 262M USD (2016)
DESCRIPTION

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure. Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options. HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (Israel) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-01 Valtech Cardio

Yehuda, Israel

Valtech Cardio Ltd. is specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR).

Buy -
Mergr

Product

Company

Legal